Concepedia

John G. Harpel

JG

Statistics

Publications

11

Citations

1.7K

H-Index

11

Active since

1993

Affiliations

New York University(Current)

NewYork–Presbyterian Hospital

Columbia University Irving Medical Center

Cornell University

New York Hospital Queens

John G. Harpel is an author at New York University specializing in medicine, cell signaling, and signal transduction.

Top concepts

Publications per year

1993–2025

11

Publications

11

An Assay for Transforming Growth Factor-β Using Cells Transfected with a Plasminogen Activator Inhibitor-1 Promoter-Luciferase Construct

Mayumi Abé, John G. Harpel, Christine N. Metz et al. · Analytical Biochemistry · 1994 · 754 citations · Full text

Interactions between Growth Factors and Integrins: Latent Forms of Transforming Growth Factor-β Are Ligands for the Integrin αvβ1

John S. Munger, John G. Harpel, Filippo G. Giancotti et al. · Molecular Biology of the Cell · 1998 · 236 citations · Full text

Role of the latent TGF-beta binding protein in the activation of latent TGF-beta by co-cultures of endothelial and smooth muscle cells.

Robert Flaumenhaft, Mayumi Abé, Yasufumi Sato et al. · The Journal of Cell Biology · 1993 · 235 citations · Full text

, , +22

BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma.

Rubén Niesvizky, David Jayabalan, Paul J. Christos et al. · Blood · 2007 · 182 citations · Full text

Stem Cell Mobilization with Cyclophosphamide Overcomes the Suppressive Effect of Lenalidomide Therapy on Stem Cell Collection in Multiple Myeloma

Tomer M. Mark, Jessica Stern, Jessica Furst et al. · Biology of Blood and Marrow Transplantation · 2008 · 115 citations · Full text

1–5 of 11